During pandemic, growth of clinicians with X-waivers for buprenorphine prescribing slowed

The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver, according to two studies published online May 12 in JAMA Network Open.
The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver, according to two studies published online May 12 in JAMA Network Open.